SGLT2 Inhibitors in Elderly and Frail CKM Patients Consistent benefit across age and frailty, with no excess hypoglycaemia. d [Internet]. 2026 Jul. 7 [cited 2026 Jul. 29];4(15):28-9. Available from: https://thediabzen.com/index.php/d/article/view/57